Funding Details
- Awarder
- Inbox
- Date Award
- May 02, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Founding Year
- 2022
- Traction
- Stately Bio has validated its technology through multiple partnerships across different cell types and use cases. In a recent preclinical study with the New York Blood Center, Stately Bio’s ML platform was able to identify specific subpopulations of stem cell-derived immune cells faster and more efficiently than gold-standard flow cytometry and immunofluorescence assays.
- Organizations Involved
- New York Blood Center
- Founders
- Frank Li
- Company Description
- Stately Bio is the trade-off between measuring cells and keeping them alive.
- Market
- Regenerative Medicine
- Location
-
Palo Alto,
California,
USA
- Coinvestors
- AIX Ventures, Dimension Capital, Foothill Ventures, Village Global, Caffeinated Capital, Mitsui Global Investment, BoxOne Ventures, Axial VC, Jeff Dean, Jeremy Wertheimer, Tom Berry
Links